Stockscreener 앱 받기
72.51
0.12%
-0.09
Avidity Biosciences Inc 주식(RNA)의 최신 뉴스
Aug Levels: Can Avidity Biosciences Inc continue delivering strong returnsTrade Ideas & Pattern Based Trade Signal System - baoquankhu1.vn
Aug PostEarnings: Can Avidity Biosciences Inc outperform in the next rallyJuly 2025 Volume & AI Driven Stock Price Forecasts - baoquankhu1.vn
Avidity Biosciences (NASDAQ:RNA) Hits New 1-Year HighHere's What Happened - MarketBeat
Avidity Biosciences stock hits all-time high at 72.63 USD - Investing.com India
Novartis (NYSE: NVS) details Avidity deal and Atrium SpinCo plans - Stock Titan
Understanding the Setup: (RNA) and Scalable Risk - Stock Traders Daily
Hedge Fund Moves: Can Avidity Biosciences Inc. stock sustain free cash flow growthMarket Trend Review & Real-Time Buy Signal Alerts - moha.gov.vn
Earnings Beat: Will Avidity Biosciences Inc outperform tech stocksJuly 2025 Levels & Fast Moving Trade Plans - baoquankhu1.vn
Avidity Biosciences, Inc. (RNA) Stock Analysis: Impressive Revenue Growth Amidst Biotech Sector Challenges - DirectorsTalk Interviews
Insider Selling: Avidity Biosciences (NASDAQ:RNA) CEO Sells 8,576 Shares of Stock - MarketBeat
Insider Selling: Avidity Biosciences (NASDAQ:RNA) Insider Sells 2,374 Shares of Stock - MarketBeat
Charles Calderaro III Sells 3,727 Shares of Avidity Biosciences (NASDAQ:RNA) Stock - MarketBeat
Novartis to acquire Avidity Biosciences for about $12B - MSN
Why Avidity Biosciences Inc. stock attracts high net worth investors2025 Historical Comparison & Free Fast Entry Momentum Trade Alerts - ulpravda.ru
Will Avidity Biosciences Inc. stock gain from strong economyOil Prices & Free Verified High Yield Trade Plans - ulpravda.ru
Avidity Biosciences (NASDAQ:RNA) Stock Crosses Above Fifty Day Moving AverageHere's Why - MarketBeat
Avidity Biosciences, Inc. (RNA) Stock Analysis: Navigating a 434% Revenue Surge and Strategic Clinical Trials - DirectorsTalk Interviews
Avidity Biosciences, Inc. (RNA) Initiated with a Strong Buy at Raymond James - MSN
The Technical Signals Behind (RNA) That Institutions Follow - Stock Traders Daily
Avidity Biosciences, Inc. (RNA) Reports Q1 Loss, Misses Revenue Estimates - sharewise.com
Is Avidity Biosciences Inc a good long term investmentStock Price Divergence & Market Monitoring and Alerts - earlytimes.in
Avidity Biosciences Earnings Notes - Trefis
Is Avidity Biosciences Inc. stock resilient to inflationSupport Zone Identification & High Return Trading Ideas - bollywoodhelpline.com
Avidity Biosciences, Inc. (RNA) Stock Analysis: Navigating a 434% Revenue Surge and Potential 3.47% Upside - DirectorsTalk Interviews
CEO Moves: Is Avidity Biosciences Inc stock a buy on dipsSwing Trade & Weekly High Return Opportunities - moha.gov.vn
Novartis to acquire Avidity Biosciences for about $12 billion - MSN
Assenagon Asset Management S.A. Has $2 Million Holdings in Avidity Biosciences, Inc. $RNA - MarketBeat
How Avidity Biosciences Inc. stock valuations compare to rivalsQuarterly Market Summary & Risk Adjusted Buy/Sell Alerts - Улправда
Exit Recap: Is Avidity Biosciences Inc. stock resilient to inflationJuly 2025 Spike Watch & Long-Term Growth Plans - ulpravda.ru
Avidity Biosciences stock hits all-time high at 72.23 USD By Investing.com - Investing.com South Africa
Avidity Biosciences stock hits all-time high at 72.23 USD - Investing.com
Officer Calderaro III Surrenders 9,726 Of Avidity Biosciences Inc [RNA] - TradingView — Track All Markets
Officer Flanagan Surrenders 13,695 Of Avidity Biosciences Inc [RNA] - TradingView — Track All Markets
Officer Mosbrooker Surrenders 47,990 Of Avidity Biosciences Inc [RNA] - TradingView — Track All Markets
Officer Gallagher Surrenders 41,366 Of Avidity Biosciences Inc [RNA] - TradingView — Track All Markets
Officer McCarthy Acquires 21,702 Of Avidity Biosciences Inc [RNA] - TradingView — Track All Markets
Avidity Biosciences (NASDAQ:RNA) Lowered to Hold Rating by Evercore ISI - MarketBeat
RNA SEC FilingsAvidity Biosciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Avidity Biosciences receives FTC clearance for Novartis merger - MSN
Avidity reports FTC granted request for early termination of HSR waiting period - MSN
Novartis-Avidity Biosciences deal gets early clearance in US - MLex
Evercore ISI Downgrades Avidity Biosciences to In Line From Outperform, Adjusts Price Target to $72 From $65 - marketscreener.com
Avidity Biosciences Receives FTC Clearance for Novartis Merger - TipRanks
Avidity Biosciences (NASDAQ:RNA) Sets New 52-Week HighHere's Why - MarketBeat
Avidity Biosciences, Inc. (NASDAQ:RNA) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Mirador Capital Partners LP Purchases 22,666 Shares of Avidity Biosciences, Inc. $RNA - MarketBeat
Top 2 Health Care Stocks That May Keep You Up At Night In December - Benzinga
Dyne upgraded at Oppenheimer on upcoming trial readout from Avidity - MSN
Frazier Life Sciences Management L.P. Has $17.75 Million Stock Holdings in Avidity Biosciences, Inc. $RNA - MarketBeat
Avidity Biosciences (NASDAQ:RNA) Reaches New 52-Week HighWhat's Next? - MarketBeat
EcoR1 Capital LLC Sells 57,576 Shares of Avidity Biosciences, Inc. $RNA - MarketBeat
Avidity Biosciences stock hits all-time high at 71.81 USD By Investing.com - Investing.com Australia
Avidity Biosciences stock hits all-time high at 71.81 USD - Investing.com
Aug Closing: Is Avidity Biosciences Inc stock vulnerable to regulatory risksTrade Performance Summary & Growth-Oriented Investment Plans - moha.gov.vn
Avoiding Lag: Real-Time Signals in (RNA) Movement - news.stocktradersdaily.com
4.73%
0.92%
자본화:
|
볼륨(24시간):